-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Pfizer, Raises Price Target to $30

Benzinga·11/05/2026 00:15:47
UBS analyst Michael Yee maintains Pfizer (NYSE:PFE) with a Neutral and raises the price target from $27 to $30.